Mobile-health Network Solutions Net Profit Margin 2023-2023 | MNDR
Mobile-health Network Solutions net profit margin from 2023 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Mobile-health Network Solutions Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.003B | $0.014B |
| Mobile-health Network Solutions is a telehealth solutions provider principally in Singapore. The company offer users with a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to user homes, as well as other personalized services such as weight management programs. Mobile-health Network Solutions is based in Singapore. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.023B | 58.55 |
| Doximity (DOCS) | United States | $11.285B | 52.24 |
| Hims & Hers Health (HIMS) | United States | $11.252B | 116.91 |
| Tempus AI (TEM) | United States | $10.318B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.301B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.107B | 64.17 |
| Hinge Health (HNGE) | United States | $3.444B | 0.00 |
| Privia Health (PRVA) | United States | $2.573B | 175.83 |
| Enovis (ENOV) | United States | $2.053B | 11.45 |
| Phreesia (PHR) | United States | $1.706B | 0.00 |
| Schrodinger (SDGR) | United States | $1.593B | 0.00 |
| Azenta (AZTA) | United States | $1.563B | 72.66 |
| 10x Genomics (TXG) | United States | $1.554B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.552B | 0.00 |
| Omnicell (OMCL) | United States | $1.395B | 24.60 |
| Evolent Health (EVH) | United States | $1.318B | 112.30 |
| Claritev (CTEV) | United States | $0.783B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Standard BioTools (LAB) | United States | $0.513B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.460B | 137.50 |
| Outset Medical (OM) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.345B | 765.33 |
| Health Catalyst (HCAT) | United States | $0.278B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.172B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| Pulmonx (LUNG) | United States | $0.107B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.90 |
| Zepp Health (ZEPP) | Netherlands | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.076B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |